SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Emile Griffith — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEmile Griffith
Date of birth1938-02-03
IdentifiersMRN HR-BX005-SYN-TD; SSN (made up) 000-05-6418
Document date2005-10-27
AuthorCeleste Fairbanks-Ochieng, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review of PTSD, mood and memory. [S]

History of Present Illness

Emile Griffith returns with his care partner. Nightmares come about once every two weeks, and he sleeps about six and a half hours most nights. He takes sertraline 50 mg each morning without side effects and asks how long he should stay on it. He walks most mornings, does his exercises and has had no falls. He visited a boxing gym in the city twice this month to watch young fighters train. His care partner has noticed no change in his memory, and he has not been lost. No thoughts of suicide. [S]

ElementDetail
PCL-520, from 41 at intake
PHQ-94; item 9 scored 0
NightmaresAbout once every two weeks
FallsNone; Timed Up and Go 10 seconds
Vaccines todayHigh-dose influenza and the second zoster dose

Review of Systems

SystemResultFinding
PsychiatricPositiveOccasional nightmares; mood good; no thoughts of suicide
NeurologicalPositiveForgetfulness unchanged; no headaches, weakness, tremor or slowness
ConstitutionalNegativeWeight stable; no fatigue
MusculoskeletalNegativeNo falls

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 25 mg oral tablet, one tablet each morningOne tablet each morningOral route2005-05-05 to 2005-06-16completedS
Sertraline 50 mg oral tablet, one tablet each morningOne tablet each morningOral route2005-06-16activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2005-10-27Body height170cmS
2005-10-27Body weight74.2kgS
2005-10-27Body mass index (BMI) [Ratio]25.7kg/m2S
2005-10-27Systolic blood pressure126mm[Hg]S
2005-10-27Diastolic blood pressure76mm[Hg]S
2005-10-27Heart rate66/minS
2005-10-27Respiratory rate14/minS
2005-10-27Body temperature36.6CelS
2005-10-27Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2005-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2005-10-27PTSD PCL-5 score [PCL-5]20{score}S

Physical Exam

Vital signs recorded on 2005-10-27; see the Vital Signs section. [S]

SystemFinding
GeneralWell and cheerful; blood pressure 126/76 mmHg; pulse 66; weight 74.2 kg
MusculoskeletalTimed Up and Go 10 seconds
Mental statusEuthymic; tells stories with fewer repetitions; no psychotic symptoms; denies thoughts of suicide

Problems

ProblemClinical statusVerificationCodeProvenance
Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be foundresolvedconfirmed R41.3S — Synthetic presenting problem anchored to the documented short-term memory problems; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.
Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41activeconfirmed F43.12S — Synthetic modern diagnosis at intake by clinical interview against DSM-5-TR criteria, anchored to his public words about lifelong nightmares; not a historical diagnosis.
Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excludedactiveconfirmed G31.84S — Synthetic modern diagnosis at the third visit after MRI and neuropsychological testing; anchored to the documented memory problems and pugilistic dementia, not a retrospective diagnosis of his real illness.
Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospitalactiveconfirmed Z87.820S — Synthetic coding of the documented career and assault.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyCognitive testing (MoCA)At diagnosis, then yearly, or sooner with changeUp to dateMoCA 22 at intake; next at the yearly review in about six months
SurveyStaging (CDR) and function (ADL and IADL)At diagnosis, then yearlyUp to dateCDR 0.5 at two weeks; function unchanged
SurveyNeuropsychological testingAt diagnosis when the cause or stage is unclear; repeat in 12 to 18 months or with changeUp to dateRepeat due in about a year
ExaminationMedicine review for anticholinergic, sedating and fall-risk drugs (Beers)Every visitCompleted todaySertraline 50 mg only
SurveyNeuropsychiatric symptom screen (apathy, irritability, paranoia, impulsivity)Every visitCompleted todayNo apathy, irritability, paranoia or impulsive behavior
SurveyPHQ-9 with suicide-risk review (item 9 and structured questions)Monthly during acute treatment; every visit during active treatmentCompleted todayPHQ-9 4 (remission), item 9 scored 0; no thoughts of suicide
SurveyPCL-5Baseline, then at each chronic-care visit during treatment; response judged after 8 to 12 weeksCompleted todayPCL-5 20
Medication safetySertraline: nausea, sleep, falls, bleeding, and sodium (SSRIs can lower sodium in older adults)Two weeks after starting and after each dose change; sodium at those pointsUp to dateNo dose change; no side effects; sodium 137 mmol/L six weeks ago
ExaminationFall risk (Timed Up and Go, gait and balance), STEADIAt diagnosis, yearly, and after any fallCompleted todayTimed Up and Go 10 seconds; no falls
Self-managementTravel, money and home safetyAt diagnosis and each follow-upCompleted todayNo episodes of getting lost; plans unchanged
SurveyCare partner support and burden (Zarit Burden Interview, narrative)At diagnosis, then every 6 to 12 monthsCompleted todayZarit 10 (little or no burden), from 14
Self-managementAdvance care planningAt diagnosis; revisit yearly and at changesUp to dateHealth care proxy on file; revisit at the next annual wellness visit
ExaminationVascular risk factors (blood pressure, weight)Every visitCompleted todayBlood pressure 126/76 mmHg; weight 74.2 kg

Goal progress:

Immunizations given today: High-dose influenza vaccine, 2005-2006 season; Recombinant zoster vaccine, dose 2 of 2 [S]

Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024); Adult Immunization Schedule by Age (2026)

Follow-up: Yearly cognitive review with MoCA and CDR in about six months, and the annual wellness visit. COVID-19 vaccine at the pharmacy next week, at his choice. Call the clinic or 988 at any time if thoughts of suicide arise. [S]